WHO ICTRP trial
A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy…
NL-OMON40874 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON40874 |
|---|---|
| Public title | A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator*s Choice in Subjects with Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy |
| Scientific title | A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator*s Choice in Subjects with Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy… |
| Primary sponsor | PRA Group BV |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Phase | 3 |
| Countries | Argentina;Brazil;Bulgaria;Canada;Chile;Denmark;France;Hungary;Israel;Italy;Korea (the Republic of);Netherlands ;Poland;Russian Federation ;Spain;United States of America |
| Conditions | soft tissue tumors; soft tissue sarcoma;10072990;soft tissue tumors; soft tissue sarcoma |
| Interventions | site bezoeken, toediening van studie medicatie, het invullen van een patientendagboekje en tijdens de gehele onderzoeksperiode: lichamelijk onderzoek, Echo, ECG, CT-scan/MRI, vitale functies meten en bloed- en urinemonsters verstrekken… |
| Registration date | Sep 26, 2014 |
| Target size | 4 |
| Secondary IDs | 2013-004103-40;NCT02049905;NL48870.058.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: